nickel acetate has been researched along with Granulocytic Leukemia, Chronic in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fan, L; Hu, A; Li, F; Liang, J; Liu, C; Mu, CF; Xiong, Y | 1 |
1 other study(ies) available for nickel acetate and Granulocytic Leukemia, Chronic
| Article | Year |
|---|---|
Dual oligopeptides modification mediates arsenic trioxide containing nanoparticles to eliminate primitive chronic myeloid leukemia cells inside bone marrow niches.
Topics: Acetates; Animals; Arsenic Trioxide; Bone Marrow; Cell Proliferation; Cells, Cultured; Drug Delivery Systems; Female; Human Umbilical Vein Endothelial Cells; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Mice; Nanoparticles; Neoplastic Stem Cells; Oligopeptides; Organometallic Compounds; Polymers; Tumor Stem Cell Assay | 2020 |